1Cell.Ai Named Best Healthtech Startup 2026
Recognised for Innovation in Precision Oncology & Patient Impact
x
1Cell.Ai Named Best Healthtech Startup 2026
Recognised for Innovation in Precision Oncology & Patient Impact
Education
Doctoral research in medical genetics, building a foundation in molecular biology and precision medicine.
POSTDOCTORAL TRAINING
Advanced training in computational medicine and data-driven approaches to clinical research.
Scientific Leadership
Led scientific initiatives and the development of advanced genomic and molecular diagnostic solutions.
1CELL.AI
Leading medical informatics and AI-driven innovation across precision oncology, molecular diagnostics, and clinical decision support.
When Plasma Can't Find It; Urine Can Plasma-based liquid biopsy has transformed how
Pancreatic Cancer's Moving Target:- Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers
The Problem That Drives MIRAGE A patient finishes surgery. Their scans look clear.
The Problem With One-Size-Fits-All Chemotherapy Every oncologist knows the reality:- Two patients with the same cancer
The Challenge We Set Out to Solve One of the most persistent challenges
AI-driven HRD biomarker prediction using OncoPredikt® deep learning inference engine trained on 1,892
The Problem That Millions of Patients Face Every Day Every year, thousands of women
The Foundation of Trust in Precision Oncology A genomic profiling assay is only as
Highlights single circulating tumor cell (sCTC) genomic profiling in advanced colorectal cancer patients.
PK
publications
RJ
publications
SI
publications
NA
publications
Discover evidence-driven publications, clinical perspectives, and scientific advances from the 1Cell.Ai team.
